These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

535 related articles for article (PubMed ID: 26767526)

  • 1. Modern Therapies for Idiopathic Inflammatory Myopathies (IIMs): Role of Biologics.
    Moghadam-Kia S; Oddis CV; Aggarwal R
    Clin Rev Allergy Immunol; 2017 Feb; 52(1):81-87. PubMed ID: 26767526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biologics for idiopathic inflammatory myopathies.
    Moghadam-Kia S; Aggarwal R; Oddis CV
    Curr Opin Rheumatol; 2017 Nov; 29(6):645-651. PubMed ID: 28817464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current and new targets for treating myositis.
    Moghadam-Kia S; Oddis CV
    Curr Opin Pharmacol; 2022 Aug; 65():102257. PubMed ID: 35724455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biologic therapy in the idiopathic inflammatory myopathies.
    Khoo T; Limaye V
    Rheumatol Int; 2020 Feb; 40(2):191-205. PubMed ID: 31680207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of rituximab treatment in patients with idiopathic inflammatory myopathies: A systematic review and meta-analysis.
    Zhen C; Hou Y; Zhao B; Ma X; Dai T; Yan C
    Front Immunol; 2022; 13():1051609. PubMed ID: 36578492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of inflammatory myopathy: emerging therapies and therapeutic targets.
    Moghadam-Kia S; Aggarwal R; Oddis CV
    Expert Rev Clin Immunol; 2015; 11(11):1265-75. PubMed ID: 26313852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Idiopathic Inflammatory Myopathies: A Review of the Classification and Impact of Pathogenesis.
    Mandel DE; Malemud CJ; Askari AD
    Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28524083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic advances in myositis.
    Aggarwal R; Oddis CV
    Curr Opin Rheumatol; 2012 Nov; 24(6):635-41. PubMed ID: 22955021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapeutic strategy in inflammatory myopathies (polymyositis, dermatomyositis, overlap myositis, and immune-mediated necrotizing myopathy)].
    Tournadre A
    Rev Med Interne; 2014 Jul; 35(7):466-71. PubMed ID: 24144868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of idiopathic inflammatory myopathies.
    Amato AA; Griggs RC
    Curr Opin Neurol; 2003 Oct; 16(5):569-75. PubMed ID: 14501840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Idiopathic inflammatory myopathies from the viewpoint of rheumatologists].
    Gono T; Katsumata Y; Kawaguchi Y
    Brain Nerve; 2013 Nov; 65(11):1275-82. PubMed ID: 24200605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myositis in clinical practice-relevance of new antibodies.
    Moghadam-Kia S; Aggarwal R; Oddis CV
    Best Pract Res Clin Rheumatol; 2018 Dec; 32(6):887-901. PubMed ID: 31427061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical trials roundup in idiopathic inflammatory myopathies.
    Mann HF; Vencovský J
    Curr Opin Rheumatol; 2011 Nov; 23(6):605-11. PubMed ID: 21926626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current diagnosis and treatment of polymyositis and dermatomyositis.
    Sasaki H; Kohsaka H
    Mod Rheumatol; 2018 Nov; 28(6):913-921. PubMed ID: 29669460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biologics in refractory myositis: experience in juvenile vs. adult myositis; part II: emerging biologic and other therapies on the horizon.
    Patwardhan A; Spencer CH
    Pediatr Rheumatol Online J; 2019 Aug; 17(1):56. PubMed ID: 31429786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Favorable rituximab response in patients with refractory idiopathic inflammatory myopathies.
    de Souza FHC; Miossi R; de Moraes JCB; Bonfá E; Shinjo SK
    Adv Rheumatol; 2018 Sep; 58(1):31. PubMed ID: 30657080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corticosteroids in Myositis and Scleroderma.
    Postolova A; Chen JK; Chung L
    Rheum Dis Clin North Am; 2016 Feb; 42(1):103-18, ix. PubMed ID: 26611554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent clinical trials in idiopathic inflammatory myopathies.
    Leclair V; Lundberg IE
    Curr Opin Rheumatol; 2017 Nov; 29(6):652-659. PubMed ID: 28763333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment in myositis.
    Oddis CV; Aggarwal R
    Nat Rev Rheumatol; 2018 May; 14(5):279-289. PubMed ID: 29593343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Classification, diagnosis, and management of idiopathic inflammatory myopathies.
    Lazarou IN; Guerne PA
    J Rheumatol; 2013 May; 40(5):550-64. PubMed ID: 23504386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.